Skip to main content
Bonyf N.V. logo

Bonyf N.V. — Investor Relations & Filings

Ticker · MLBON ISIN · BE6333353298 LEI · 699400NGN0HE0QBIF505 BR Manufacturing
Open in API
Filings indexed 6 across all filing types
Latest filing 2025-10-15 Regulatory Filings
Country BE Belgium
Listing BR MLBON

About Bonyf N.V.

https://bonyf.com/

Bonyf N.V. is a company specializing in the research, development, production, and distribution of products for oral, dental, orthodontic, and dermatological care. The company develops clinically validated solutions for dental professionals, pharmacies, and consumers. Its portfolio includes care products for removable oral appliances such as dentures, retainers, and orthodontic devices. Key innovations are based on its patented NitrAdine® formulation, which is used in products like disinfecting tablets and PerioCream, a mucoadhesive paste for professional periodontal treatment. Bonyf focuses on providing high-quality, certified medical device solutions to improve patient well-being.

Recent filings

Filing Released Lang Actions
bonyf AG receives the EU-MDR Certification Class IIa for PerioCream
Regulatory Filings Classification · 100% confidence The document is a press release issued by bonyf NV announcing that its brand, PerioCream, has received EU-MDR Certification Class IIa. It provides details about the product, the regulatory certification, and the company's market strategy. As this is a general corporate announcement regarding product development and regulatory status that does not fit into specific financial reporting categories like earnings or dividends, it falls under the 'Regulatory Filings' (RNS) category, which serves as the fallback for general corporate news disseminated via financial wire services.
2025-10-15 English
bonyf NV Showcases Innovative Product Portfolio at ExpoPharm 2025 in Dusseldorf
Regulatory Filings Classification · 100% confidence The document is a press release announcing the company's participation in a trade fair (ExpoPharm 2025). It does not contain financial results, board changes, or regulatory filings, but rather serves as a general corporate news announcement disseminated via a financial wire service. Since it does not fit into specific categories like earnings or reports, it falls under the general regulatory/corporate announcement category.
2025-09-15 English
bonyf NV Cancels Planned Capital Increase Following Positive Strategic Developments
Share Issue/Capital Change Classification · 100% confidence The document is a press release announcing the cancellation of a previously planned capital increase by bonyf NV. It discusses corporate financing strategy and business developments. While it mentions financing, it is an announcement of a corporate action rather than a formal capital raising document or a regulatory filing for a share issue. Given the specific nature of the announcement regarding a change in capital structure plans, it fits best under 'Capital/Financing Update'.
2025-09-05 English
Periocream: The Future Commercial Winner for bonyf
Regulatory Filings Classification · 95% confidence The document is a press release issued by bonyf NV regarding the upcoming market launch of a new product, 'Periocream'. It details the product's clinical status, regulatory progress (FDA/European Class IIa), and commercial rollout strategy. It is disseminated via a financial wire service (EQS Group) and functions as a corporate news announcement rather than a formal financial report, audit, or proxy statement. As it does not fit into specific categories like M&A, dividends, or director dealings, it falls under the general regulatory/corporate announcement category.
2025-08-11 English
bonyf Reaffirms Its Long-Term Vision Amid Short-Term Market Volatility
Regulatory Filings Classification · 99% confidence The document is a corporate news release dated July 14, 2025, titled "bonyf Reaffirms Its Long-Term Vision Amid Short-Term Market Volatility." It discusses revenue projections (€5 million), operational updates (India JV launch, US market progress), strategic plans (dual listing preparation), and addresses short-term stock pressure. This content is characteristic of an Earnings Release (ER) or a Management Discussion/Analysis (MDA) if it were part of a formal report. However, since it is a standalone news announcement focusing on financial outlook, operational milestones, and management commentary outside of a formal quarterly/annual filing structure, it aligns best with an Earnings Release (ER) which provides key highlights and management commentary following a period or in anticipation of results. It is not a full report (10-K or IR), a transcript (CT), or a formal proxy/governance document. Given the focus on reaffirming vision and providing revenue guidance, ER is the most appropriate fit among the options provided for a general corporate update of this nature.
2025-07-14 English
Annual Results 2024
Earnings Release Classification · 100% confidence The document is titled "Annual Results 2024" and explicitly states that the company "presents its 2024 financial statements, approved by its Board of Directors and audited by its Statutory Auditors." This strongly indicates the release of the full annual financial performance report. However, the document itself is very short (3341 characters) and appears to be a press release or announcement summarizing the results and pointing to the full document via a link ("![fncls.ssp?fn=download2_file&code_str=e85e981fac02af77ded9ef12b9383f31]"). According to Rule #2 (The "MENU VS MEAL" Rule), a short announcement pointing to the full report should be classified as a Report Publication Announcement (RPA). If the text contained the full financial statements, it would be classified as 10-K. Since it is an announcement of the Annual Results, RPA is the most appropriate classification based on the provided definitions and rules. FY 2024
2025-06-30 English

Browse filings by year

1 year

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.